Literature DB >> 18475626

Modulation of oxazolone-induced hypersensitivity in mice by selective PDE inhibitors.

I Moodley1, Y Sotsios, B Bertin.   

Abstract

The effects of PDE inhibitors on oxazolone-induced contact hypersensitivity (CS) were studied in mice. Rolipram, Ro 20-1724 and theophylline dose dependently inhibited CS but none caused >53% inhibition. ED(30) values at 24 h before challenge for rolipram, Ro 20-1724 and theophylline were 2.1, 5.4 and 30.4 mg/kg, p.o., respectively. Milrinone and SKF 94836 at 30 mg/kg caused a small, but significant inhibition of 13% and 18%, respectively, although the inhibition (8%) caused by zaprinast was not significant. Betamethasone (10 mg/kg, p.o.) caused a marked inhibition (80%) as did indomethacin (65% at 5 mg/kg, p.o.). Rolipram and Ro 20-1724 inhibited proliferation of mouse lymphoblasts with IC(50) values of 0.08 muM and 0.83 muM, respectively. In contrast, zaprinast caused only a weak inhibition (IC(50) = 119 muM) of lymphocyte proliferation, whereas SKF 94836 and theophylline failed to cause any significant inhibition at 100 muM (26% and 2%, respectively). These findings suggest that PDE IV isozymes play a principal role in mediating CS by inhibiting lymphocyte activation.

Entities:  

Year:  1995        PMID: 18475626      PMCID: PMC2365615          DOI: 10.1155/S0962935195000196

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  16 in total

Review 1.  Functional subsets of allergen-reactive human CD4+ T cells.

Authors:  M L Kapsenberg; E A Wierenga; J D Bos; H M Jansen
Journal:  Immunol Today       Date:  1991-11

Review 2.  Cyclic nucleotide phosphodiesterases: pharmacology, biochemistry and function.

Authors:  W J Thompson
Journal:  Pharmacol Ther       Date:  1991       Impact factor: 12.310

3.  Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.

Authors:  P Marcoz; A F Prigent; M Lagarde; G Nemoz
Journal:  Mol Pharmacol       Date:  1993-11       Impact factor: 4.436

4.  Cyclic AMP directly inhibits IL-2 receptor expression in human T cells: expression of both p55 and p75 subunits is affected.

Authors:  D S Krause; C Deutsch
Journal:  J Immunol       Date:  1991-04-01       Impact factor: 5.422

5.  Effects of cyclic AMP- and cyclic GMP- phosphodiesterase inhibitors on immunological release of histamine and on lung contraction.

Authors:  N Frossard; Y Landry; G Pauli; M Ruckstuhl
Journal:  Br J Pharmacol       Date:  1981-08       Impact factor: 8.739

6.  Multiple high-affinity cAMP-phosphodiesterases in human T-lymphocytes.

Authors:  S A Robicsek; D K Blanchard; J Y Djeu; J J Krzanowski; A Szentivanyi; J B Polson
Journal:  Biochem Pharmacol       Date:  1991-07-25       Impact factor: 5.858

7.  Effects of isozyme-selective phosphodiesterase inhibitors on eosinophil infiltration in the guinea-pig lung.

Authors:  V Lagente; I Moodley; S Perrin; G Mottin; J L Junien
Journal:  Eur J Pharmacol       Date:  1994-04-01       Impact factor: 4.432

8.  Phosphodiesterase inhibition by Ro 20-1724 reduces hyper-IgE synthesis by atopic dermatitis cells in vitro.

Authors:  K D Cooper; K Kang; S C Chan; J M Hanifin
Journal:  J Invest Dermatol       Date:  1985-06       Impact factor: 8.551

9.  Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones.

Authors:  D J Cher; T R Mosmann
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

10.  Cyclic AMP inhibits phosphatidylinositol-coupled and -uncoupled mitogenic signals in T lymphocytes. Evidence that cAMP alters PKC-induced transcription regulation of members of the jun and fos family of genes.

Authors:  A Tamir; N Isakov
Journal:  J Immunol       Date:  1994-04-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.